DIHEXA 10mg

Description

DIHEXA, also known as N-hexanoic-Tyr-Ile- (6) aminohexanoic amide, is a synthetic peptide derived from angiotensin IV. It was developed by researchers at Washington State University with the goal of improving cognitive functions and treating neurodegenerative disorders. Originally developed to investigate mechanisms of neuronal growth and synaptic plasticity, DIHEXA is of interest in studies of neurodegenerative processes, memory, and cognitive function. Preclinical studies have shown that Dihexa has potential in the treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.

In research settings, DIHEXA is used to explore neurogenesis, synaptic connectivity, and peptide-mediated brain signaling pathways. The peptide is supplied in lyophilized form to preserve stability and allow precise reconstitution for experimental use.

Each batch is manufactured using high-quality solid-phase peptide synthesis and undergoes rigorous analytical testing to ensure purity, molecular identity, and consistency required for controlled scientific studies.

This peptide is intended for use only in controlled scientific environments and by professionals familiar with proper peptide handling and laboratory standards.

Research Use Only Disclaimer
This product is sold strictly for laboratory research, analytical, and scientific purposes only. It is not intended for human consumption, veterinary use, diagnostic use, therapeutic application, or personal use of any kind. By purchasing this product, the customer confirms that the material will be handled only by qualified professionals in an appropriate research setting.